SONUS PHARMACEUTICALS INC
10-Q, EX-27.1, 2000-11-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: SONUS PHARMACEUTICALS INC, 10-Q, EX-10.44, 2000-11-14
Next: CFC INTERNATIONAL INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       6,063,463
<SECURITIES>                                 9,222,954
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            15,694,744
<PP&E>                                       4,050,775
<DEPRECIATION>                             (3,485,614)
<TOTAL-ASSETS>                              16,259,905
<CURRENT-LIABILITIES>                        7,882,874
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    37,726,876
<OTHER-SE>                                (29,349,845)
<TOTAL-LIABILITY-AND-EQUITY>                16,259,905
<SALES>                                              0
<TOTAL-REVENUES>                                68,338
<CGS>                                                0
<TOTAL-COSTS>                                2,403,347
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (4,998)
<INCOME-PRETAX>                            (2,166,335)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,166,335)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,166,335)
<EPS-BASIC>                                     (0.24)
<EPS-DILUTED>                                   (0.24)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission